Increasing the number of adverse drug reactions reporting: The role of clinical pharmacy residents

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue 1, 2014, Pages 291-297

  Baniasadi, Shadi ^a   Habibi, Maryam ^b   Haghgoo, Roodabeh ^b   Gamishan, Masoumeh Karimi ^c   Dabaghzadeh, Fatemeh ^d   Farasatinasab, Maryam ^e   Farsaei, Shadi ^f   Gharekhani, Afshin ^g   Kafi, Hamidreza ^e   Karimzadeh, Iman ^g   Kharazmkia, Ali ^h   Najmeddin, Farhad ^g   Nikvarz, Naemeh ^d   Oghazian, Mohammad Bagher ^g   Rezaee, Haleh ⁱ   Sadeghi, Kourosh ^g   Tafazzoli, Ali ^e   Shahsavari, Nahid ^e   Fahimi, Fanak ^b,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adverse drug reaction; Clinical pharmacist; Hospital; Pharmacovigilance; Pharmacy resident; Spontaneous reporting

Indexed keywords

ALLOPURINOL; AMIODARONE; BETAXOLOL; CARBAMAZEPINE; CARBOPLATIN; CEFTRIAXONE; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIGOXIN; ENOXAPARIN; ETHAMBUTOL; HEPARIN; ISONIAZID; ISOPHANE INSULIN; MORPHINE SULFATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PIG INSULIN; PROPRANOLOL; PYRAZINAMIDE; RANITIDINE; RIFAMPICIN; SCOPOLAMINE; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN; WARFARIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ANEMIA; ARTICLE; BRONCHOSPASM; CHILD; CLINICAL PHARMACY; CONVULSION; DERMATITIS; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ECCHYMOSIS; FEMALE; HEMATURIA; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; KIDNEY DISEASE; KIDNEY FAILURE; LEUKOPENIA; LUNG EDEMA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; PANCYTOPENIA; PERIPHERAL EDEMA; PHARMACIST ATTITUDE; PROFESSIONAL STANDARD; STEVENS JOHNSON SYNDROME; STOMACH ULCER; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84896716897     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Pushkin R, Frassetto L, Tsourounis C, Segal ES and Kim S. Improving the reporting of adverse drug reactions in the hospital setting. Postgrad. Med. (2010) 122: 154-164.
2. Murphy BM and Frigo LC. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp. Pharm. (1993) 28: 1204-1240.
3. Moride Y, Haramburu F, Requeyo AA and Begaud B. Underreporting of adverse drug reactions in general practice. Br. J. Clin. Pharmacol. (1997) 43: 177-181.
4. Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, and Vega T and Martin Arias LH. Under reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur. J. Clin. Pharmacol. (1998) 54: 483-488.
5. Sullivan KM and Spooner LM. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital. Am. J. Health. Syst. Pharm. (2008) 65: 1177-1179.
6. Salamzadeh J. Clinical pharmacy in Iran: where do we stand? Iran. J. Pharm. Res. (2004) 3: 1-2.
7. Miller RR. History of clinical pharmacy and clinical pharmacology. J. Clin. Pharmacol. (1981) 21: 195-197.
8. Bond CA and Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherap. (2006) 26: 735-747.
9. Uppsala Monitoring Centre. Adverse Reaction Terminology. World Health Organization Collaborating Centre for International Drug Monitoring. Uppsala, Sweden (2003).
10. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA and Janecek E. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. (1981) 30: 239-245.
11. Schumock GT and Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp. Pharm. (1992) 27: 538.
12. Baniasadi S, Fahimi F and Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin. Pharmacol. Toxicol. (2008) 102: 408-411.
13. Hayatshahi A, Javadi MR, Sarayani A and Gholami K. Clinical pharmacy residency in Iran. ACCP International Clinical 2013 Summer [cited 2013 Oct. 22]. Available from:URL: http://www.accp.com/docs/international/0813.pdf.
14. Hemerson P and Izakovic M. Hospitalist-pharmacist collaboration. A success story of the integration of a clinical pharmacist on the multidisciplinary hospitalist team. Bratisl. Lek. Listy. (2011) 112: 88-91.
15. Ratz Y, Shafir I, Berkovitch S, Sharristh M, Jacoby M, Kozer E, Golik A, Berkovitch M and Bar-Haim S. The importance of the pharmacist in reporting adverse drug reactions in the emergency department. J. Clin. Pharmacol. (2010) 50: 1217-1221.
16. Jose J and Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol. Res. (2006) 54: 226-233.
17. Runciman WB, Roughead EE, Semple SJ and Adams RJ. Adverse drug events and medication errors in Australia. Int. J. Qual. Health Care (2003) 15: 49-59.
18. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK and Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. (2004) 329: 15-19.
19. Camargo AL, Cardoso Ferreira MB and Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a University hospital. Eur. J. Clin. Pharmacol. (2006) 62: 143-149.
20. Schneeweiss S, Göttler M, Hasford J, Swoboda W, Hippius M, Hoffmann AK, Riethling AK and Krappweis J. First results from an intensified monitoring system to estimate drug-related hospital admissions. Br. J. Clin. Pharmacol. (2001) 52: 196-200.
21. Suh DC, Woodall BS, Shin SK and Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann. Pharmacother. (2000) 34: 1373-1379.
22. Baniasadi S, Fahimi F and Namdar R. Development of an adverse drug reaction bulletin in a teaching hospital. Formulary (2009) 44: 333-335.
23. Fahimi F, Sahraee Z and Amini S. Evaluation of Stat Orders in a Teaching Hospital. Clinical Drug Invest. (2011) 31: 231-235.
24. Fahimi F. Implementation of a clinical pharmacy education program in a teaching hospital: Resident oriented documentation and intervention. Iran. J. Pharm. Res. (2010) 9: 297-302.
25. Allameh Z, Mehrpooya M, Baniasadi S and Fahimi F. Clinical pharmacy services in an Iranian teaching hospital: Type, severity, resolution, and accuracy. J. Res. Pharm. Practice. (2013) 2: 10-17.
26. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R and Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am. J. Health Syst. Pharm. (2003) 60: 1750-1759.
27. Baniasadi S and Fahimi F. Adverse drug reactions in a pulmonary teaching hospital: incidence, pattern, seriousness, and preventability. Curr. Drug Saf. (2011) 6: 230-236.
28. Fahimi F, Baniasadi S and Amini S. Adverse drug reactions in the post coronary care unit inpatients of a teaching hospital. Iran. J. Pharm. Res. (2008) 7: 223-228.
29. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Schweitzer BJ, Shea BF, Hallisey R, Vander Vliet M, Nemeskal R, Leape LL, Bates D, Hojnowski-Diaz P, Petrycki S, Cotugno M, Patterson H, Hickey M, Kleefield S, Cooper J, Kinneally E, Demonaco HJ, Clapp MD, Gallivan T, Jeanette Ives, Porter K, Thompson BT, Hackman R and Edmondson A. ADE Prevention Group. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. (1995) 274: 29-34.
30. Ducharme MM and Boothby LA. Analysis of adverse drug reactions for preventability. Int. J. Clin. Pract. (2007) 61: 157-161.
31. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR and Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. (2009) 4: 4439.
32. Dabaghzadeh F, Rashidian A, Torkamandi H, Alahyari S, Hanafi S, Farsaei S and Javadi MR. Medication errors in an emergency department in a large teaching hospital in Tehran. Iran. J. Pharm. Res. (2013) 12: 937-942.
33. Sadeghiana, Leila Safaeian GH, Mahdanian AR, Salami S and Kebriaee-Zadeh J. Prescribing quality in medical specialists in Isfahan, Iran. Iran. J. Pharm. Res. (2013) 12: 235-241.